Purpose: To investigate whether plasma rich in growth factors (PRGF) eye drops maintain
their biological potential after a freeze drying process. The addition of a lyoprotectant like …

Purpose: To analyze whether plasma rich in growth factors (PRGFs) eye drops preserve
their activity and biological properties after storage for 9 and 12 months at− 20 C, and at 4 C …

Purpose: To analyze whether plasma rich in growth factors (PRGF) eye drops preserve their
biological characteristics and activity after storage for 3 and 6 months at− 20 C, at 4 C, and at …

We have developed and characterized a new type of plasma rich in growth factors (PRGF)
derived eye-drop therapy for patients suffering from autoimmune diseases. To determine the …

Autologous serum (AS) eye drops was the first blood-derived product used for the treatment
of corneal pathologies but nowadays PRGF arises as a novel interesting alternative to this …

Purpose: The purpose of this study was to analyze the biological content and activity of
freeze-dried plasma rich in growth factors eye drops after their storage at 4° C and at room …

The purpose of this study was to analyze the proteomic composition of plasma rich in growth
factors eye drops (PRGF) in comparison to lyophilized PRGF eye drops (PRGF lyo). The …

Purpose: The purpose of this work is to describe and review the technology of plasma rich in
growth factors (PRGF), a novel blood derivative product, in the treatment of ocular surface …

This study evaluated the efficacy of Plasma rich in growth factors (PRGF-Endoret) on the
corneal wound healing process after Photorefractive keratectomy (PRK). To address this …

Purpose: We evaluated whether plasma rich in growth factors eye drops maintain their
composition and biological activity after storage for 3 months at− 20 C and after storage at 4 …